Clinical Trial Update: Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children [Phase 2]

View source ↗

Summary

This update reports on the completion of a Phase 2 study of pentostatin for high-risk and refractory chronic graft-versus-host disease in pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Pentostatin (pentostatin)

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Graft vs Host Disease | Phase 2 | Status: COMPLETED